Legend Biotech annual stock-based compensation
2018
2019
2020
2021
2022
2023
2024
2025
Legend Biotech Stock-Based Compensation Growth & History (LEGN)
Legend Biotech's stock-based compensation was $64.6M for fiscal 2025.
View full Legend Biotech company overviewLegend Biotech annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $64.6M | −$4.3M | −6.24% |
| 2024 | 2024-12-31 | $68.9M | $21.2M | +44.44% |
| 2023 | 2023-12-31 | $47.7M | $13.4M | +38.91% |
| 2022 | 2022-12-31 | $34.3M | $14.2M | +70.34% |
| 2021 | 2021-12-31 | $20.2M | $15.4M | +323.49% |
| 2020 | 2020-12-31 | $4.8M | $3.5M | +274.21% |
| 2019 | 2019-12-31 | $1.3M | $568,000 | +80.68% |
| 2018 | 2018-12-31 | $704,000 | — | — |
Legend Biotech quarterly stock-based compensation
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $17.4M | −$1.3M | −6.94% |
| Q1 2026 | 2026-03-31 | $19.3M | $3.4M | +21.03% |
| Q4 2025 | 2025-12-31 | $14.9M | $1.6M | +11.95% |
| Q3 2025 | 2025-09-30 | $15.0M | −$96,000 | −0.64% |
| Q2 2025 | 2025-06-30 | $18.7M | −$3.0M | −13.99% |
| Q1 2025 | 2025-03-31 | $15.9M | −$2.8M | −14.74% |
| Q4 2024 | 2024-12-31 | $13.3M | $738,000 | +5.85% |
| Q3 2024 | 2024-09-30 | $15.1M | $2.7M | +22.09% |
| Q2 2024 | 2024-06-30 | $21.7M | $6.1M | +38.95% |
| Q1 2024 | 2024-03-31 | $18.7M | $11.6M | +164.58% |
| Q4 2023 | 2023-12-31 | $12.6M | — | — |
| Q3 2023 | 2023-09-30 | $12.4M | $2.1M | +20.87% |
| Q2 2023 | 2023-06-30 | $15.6M | — | — |
| Q1 2023 | 2023-03-31 | $7.1M | — | — |
| Q3 2022 | 2022-09-30 | $10.2M | — | — |
Legend Biotech stock-based compensation trends
Over the last five fiscal years, Legend Biotech's stock-based compensation increased from $4.8M to $64.6M, a change of $59.8M. The latest reported quarter, Q2 2026, shows $17.4M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Legend Biotech source filings ↗